These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32628029)

  • 1. Pheochromocytoma and paraganglioma genetic testing: Psychological impact.
    Martins RG; Carvalho IP
    Health Psychol; 2020 Oct; 39(10):934-943. PubMed ID: 32628029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.
    Martins RG; Carvalho IP
    J Cancer Educ; 2020 Oct; 35(5):1026-1033. PubMed ID: 31227996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
    Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.
    Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY
    J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history.
    Alobuia WM; Ammar S; Tyagi M; Ghosh C; Gunda V; Annes JP; Kebebew E
    Surgery; 2021 Feb; 169(2):298-301. PubMed ID: 33023754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for pheochromocytoma and paraganglioma: SDHx carriers' experiences.
    Martins RG; Carvalho IP
    J Genet Couns; 2021 Jun; 30(3):872-884. PubMed ID: 33604970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
    Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
    APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
    Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary pheochromocytoma and paraganglioma].
    Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
    Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile-onset hereditary pheochromocytoma-paraganglioma syndrome.
    Sugisawa C; Okada Y; Arao T; Mori H; Nishida K; Isobe K; Takekoshi K; Tanaka Y
    Intern Med; 2013; 52(2):281-4. PubMed ID: 23318864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
    Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
    Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Informing Patients About New Genetic Testing.
    Romero Arenas MA; Grubbs EG
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):559-560. PubMed ID: 30617867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.